Upstream To Downstream: A Comprehensive Approach To AAV Production
Source: Thermo Fisher Scientific
The gene therapy industry is facing challenges in producing high titer Adeno-Associated Virus (AAV) at clinical and commercial scales within strict timelines. Paula Decaria and Chiu Lau-Barre from Thermo Fisher Scientific discuss strategies to meet growing AAV production demands and answer related queries. The webinar will address issues in scaling up AAV manufacturing, facilitating AAV production using single-use bioreactors at different scales, and methods to enhance recovery and purity in downstream processing.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more